Table of Contents List of Tables List of Figures Introduction Global Markets Direct Report Coverage Left Ventricular Dysfunction - Overview Left Ventricular Dysfunction - Therapeutics Development Pipeline Overview Pipeline by Companies Products under Development by Companies Left Ventricular Dysfunction - Therapeutics Assessment Assessment by Target Assessment by Mechanism of Action Assessment by Route of Administration Assessment by Molecule Type Left Ventricular Dysfunction - Companies Involved in Therapeutics Development Bayer AG Innopharmax Inc Mesoblast Ltd Quantum Genomics SA Takeda Pharmaceutical Co Ltd Left Ventricular Dysfunction - Drug Profiles AlloCSC-01 - Drug Profile Product Description Mechanism Of Action R&D Progress carvedilol CR - Drug Profile Product Description Mechanism Of Action R&D Progress firibastat IR - Drug Profile Product Description Mechanism Of Action R&D Progress fulacimstat - Drug Profile Product Description Mechanism Of Action R&D Progress MPC-150IM - Drug Profile Product Description Mechanism Of Action R&D Progress NP-202 - Drug Profile Product Description Mechanism Of Action R&D Progress VBC-01 - Drug Profile Product Description Mechanism Of Action R&D Progress Left Ventricular Dysfunction - Dormant Projects Left Ventricular Dysfunction - Discontinued Products Appendix Methodology Coverage Secondary Research Primary Research Expert Panel Validation Contact Us Disclaimer

List of Tables Number of Products under Development for Left Ventricular Dysfunction, H1 2019 Number of Products under Development by Companies, H1 2019 Products under Development by Companies, H1 2019 Number of Products by Stage and Target, H1 2019 Number of Products by Stage and Mechanism of Action, H1 2019 Number of Products by Stage and Route of Administration, H1 2019 Number of Products by Stage and Molecule Type, H1 2019 Left Ventricular Dysfunction - Pipeline by Bayer AG, H1 2019 Left Ventricular Dysfunction - Pipeline by Innopharmax Inc, H1 2019 Left Ventricular Dysfunction - Pipeline by Mesoblast Ltd, H1 2019 Left Ventricular Dysfunction - Pipeline by Quantum Genomics SA, H1 2019 Left Ventricular Dysfunction - Pipeline by Takeda Pharmaceutical Co Ltd, H1 2019 Left Ventricular Dysfunction - Dormant Projects, H1 2019 Left Ventricular Dysfunction - Discontinued Products, H1 2019List of Figures Number of Products under Development for Left Ventricular Dysfunction, H1 2019 Number of Products under Development by Companies, H1 2019 Number of Products by Targets, H1 2019 Number of Products by Stage and Targets, H1 2019 Number of Products by Mechanism of Actions, H1 2019 Number of Products by Stage and Mechanism of Actions, H1 2019 Number of Products by Routes of Administration, H1 2019 Number of Products by Stage and Routes of Administration, H1 2019 Number of Products by Molecule Types, H1 2019 Number of Products by Stage and Molecule Types, H1 2019

Bayer AG Innopharmax Inc Mesoblast Ltd Quantum Genomics SA Takeda Pharmaceutical Co Ltd